Polymorphism in the tumor necrosis factor-α promotor region and in the heat shock protein 70 genes associated with malignant tumors

Lotfi Chouchane, Slim Ben Ahmed, Sami Baccouche, Sami Remadi

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

BACKGROUND. Tumor necrosis factors (TNFs) and heat shock protein 70 (hsp70) are determining factors in immunologic mechanisms to tumor cells. The authors designed a case-controlled study to investigate the potential association of the polymorphisms of TNF-α and of hsp70-2 and hsp70-hom genes with malignant tumors. METHODS. The authors used an allele specific polymerase chain reaction to characterize the variation of the TNF-α promotor region in 124 unrelated Tunisian patients with malignant tumors (non-Hodgkin's lymphoma, breast carcinoma, and other tumors) and 106 healthy control subjects. Using polymerase chain reaction and restriction enzyme digestion, polymorphic analysis of hsp70-2 and hsp70-hom genes was performed in patients with non-Hodgkin's lymphoma, in those with breast carcinoma, and in control subjects. RESULTS. Analysis of TNF-α polymorphism in patients with malignant tumors and in control subjects demonstrated a high relative frequency of the TNF2 allele in the cancer patients. The relative risk (RR) of lymphoma was especially high in association with TNF1/TNF2 heterozygotes (RR = 6.7; P ≤ 0.0001), Polymorphism analysis of the hsp70-2 and hsp70-hom genes in patients with lymphoma and in those with breast carcinoma revealed that these patients had highly significant differences in the genotypic distribution of these biallelic loci compared with the control subjects. Homozygosity for one hsp70-2 allele was significantly associated with lymphoma (RR = 18.2; P ≤ 0.0001) and with breast carcinoma (RR = 16.3; P ≤ 0.001). CONCLUSIONS. Tunisian persons carrying the TNF2 allele may have an increased risk of cancer. In this study, non-Hodgkin's lymphoma and breast carcinoma were significantly associated with polymorphism in hsp70 genes.

Original languageEnglish
Pages (from-to)1489-1496
Number of pages8
JournalCancer
Volume80
Issue number8
DOIs
Publication statusPublished - 15 Oct 1997
Externally publishedYes

Fingerprint

HSP70 Heat-Shock Proteins
Genetic Promoter Regions
Tumor Necrosis Factor-alpha
Tumor Necrosis Factors
Genes
Neoplasms
Breast Neoplasms
Non-Hodgkin's Lymphoma
Lymphoma
Alleles
Polymerase Chain Reaction
Immunologic Factors
Heterozygote
Gene Frequency
Digestion
Healthy Volunteers

Keywords

  • Cancer
  • Heat shock proteins
  • Polymorphism
  • Tumor necrosis factor

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Polymorphism in the tumor necrosis factor-α promotor region and in the heat shock protein 70 genes associated with malignant tumors. / Chouchane, Lotfi; Ahmed, Slim Ben; Baccouche, Sami; Remadi, Sami.

In: Cancer, Vol. 80, No. 8, 15.10.1997, p. 1489-1496.

Research output: Contribution to journalArticle

@article{66387f5abd9f40c185bd4c6e4037d6e0,
title = "Polymorphism in the tumor necrosis factor-α promotor region and in the heat shock protein 70 genes associated with malignant tumors",
abstract = "BACKGROUND. Tumor necrosis factors (TNFs) and heat shock protein 70 (hsp70) are determining factors in immunologic mechanisms to tumor cells. The authors designed a case-controlled study to investigate the potential association of the polymorphisms of TNF-α and of hsp70-2 and hsp70-hom genes with malignant tumors. METHODS. The authors used an allele specific polymerase chain reaction to characterize the variation of the TNF-α promotor region in 124 unrelated Tunisian patients with malignant tumors (non-Hodgkin's lymphoma, breast carcinoma, and other tumors) and 106 healthy control subjects. Using polymerase chain reaction and restriction enzyme digestion, polymorphic analysis of hsp70-2 and hsp70-hom genes was performed in patients with non-Hodgkin's lymphoma, in those with breast carcinoma, and in control subjects. RESULTS. Analysis of TNF-α polymorphism in patients with malignant tumors and in control subjects demonstrated a high relative frequency of the TNF2 allele in the cancer patients. The relative risk (RR) of lymphoma was especially high in association with TNF1/TNF2 heterozygotes (RR = 6.7; P ≤ 0.0001), Polymorphism analysis of the hsp70-2 and hsp70-hom genes in patients with lymphoma and in those with breast carcinoma revealed that these patients had highly significant differences in the genotypic distribution of these biallelic loci compared with the control subjects. Homozygosity for one hsp70-2 allele was significantly associated with lymphoma (RR = 18.2; P ≤ 0.0001) and with breast carcinoma (RR = 16.3; P ≤ 0.001). CONCLUSIONS. Tunisian persons carrying the TNF2 allele may have an increased risk of cancer. In this study, non-Hodgkin's lymphoma and breast carcinoma were significantly associated with polymorphism in hsp70 genes.",
keywords = "Cancer, Heat shock proteins, Polymorphism, Tumor necrosis factor",
author = "Lotfi Chouchane and Ahmed, {Slim Ben} and Sami Baccouche and Sami Remadi",
year = "1997",
month = "10",
day = "15",
doi = "10.1002/(SICI)1097-0142(19971015)80:8<1489::AID-CNCR17>3.0.CO;2-1",
language = "English",
volume = "80",
pages = "1489--1496",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

TY - JOUR

T1 - Polymorphism in the tumor necrosis factor-α promotor region and in the heat shock protein 70 genes associated with malignant tumors

AU - Chouchane, Lotfi

AU - Ahmed, Slim Ben

AU - Baccouche, Sami

AU - Remadi, Sami

PY - 1997/10/15

Y1 - 1997/10/15

N2 - BACKGROUND. Tumor necrosis factors (TNFs) and heat shock protein 70 (hsp70) are determining factors in immunologic mechanisms to tumor cells. The authors designed a case-controlled study to investigate the potential association of the polymorphisms of TNF-α and of hsp70-2 and hsp70-hom genes with malignant tumors. METHODS. The authors used an allele specific polymerase chain reaction to characterize the variation of the TNF-α promotor region in 124 unrelated Tunisian patients with malignant tumors (non-Hodgkin's lymphoma, breast carcinoma, and other tumors) and 106 healthy control subjects. Using polymerase chain reaction and restriction enzyme digestion, polymorphic analysis of hsp70-2 and hsp70-hom genes was performed in patients with non-Hodgkin's lymphoma, in those with breast carcinoma, and in control subjects. RESULTS. Analysis of TNF-α polymorphism in patients with malignant tumors and in control subjects demonstrated a high relative frequency of the TNF2 allele in the cancer patients. The relative risk (RR) of lymphoma was especially high in association with TNF1/TNF2 heterozygotes (RR = 6.7; P ≤ 0.0001), Polymorphism analysis of the hsp70-2 and hsp70-hom genes in patients with lymphoma and in those with breast carcinoma revealed that these patients had highly significant differences in the genotypic distribution of these biallelic loci compared with the control subjects. Homozygosity for one hsp70-2 allele was significantly associated with lymphoma (RR = 18.2; P ≤ 0.0001) and with breast carcinoma (RR = 16.3; P ≤ 0.001). CONCLUSIONS. Tunisian persons carrying the TNF2 allele may have an increased risk of cancer. In this study, non-Hodgkin's lymphoma and breast carcinoma were significantly associated with polymorphism in hsp70 genes.

AB - BACKGROUND. Tumor necrosis factors (TNFs) and heat shock protein 70 (hsp70) are determining factors in immunologic mechanisms to tumor cells. The authors designed a case-controlled study to investigate the potential association of the polymorphisms of TNF-α and of hsp70-2 and hsp70-hom genes with malignant tumors. METHODS. The authors used an allele specific polymerase chain reaction to characterize the variation of the TNF-α promotor region in 124 unrelated Tunisian patients with malignant tumors (non-Hodgkin's lymphoma, breast carcinoma, and other tumors) and 106 healthy control subjects. Using polymerase chain reaction and restriction enzyme digestion, polymorphic analysis of hsp70-2 and hsp70-hom genes was performed in patients with non-Hodgkin's lymphoma, in those with breast carcinoma, and in control subjects. RESULTS. Analysis of TNF-α polymorphism in patients with malignant tumors and in control subjects demonstrated a high relative frequency of the TNF2 allele in the cancer patients. The relative risk (RR) of lymphoma was especially high in association with TNF1/TNF2 heterozygotes (RR = 6.7; P ≤ 0.0001), Polymorphism analysis of the hsp70-2 and hsp70-hom genes in patients with lymphoma and in those with breast carcinoma revealed that these patients had highly significant differences in the genotypic distribution of these biallelic loci compared with the control subjects. Homozygosity for one hsp70-2 allele was significantly associated with lymphoma (RR = 18.2; P ≤ 0.0001) and with breast carcinoma (RR = 16.3; P ≤ 0.001). CONCLUSIONS. Tunisian persons carrying the TNF2 allele may have an increased risk of cancer. In this study, non-Hodgkin's lymphoma and breast carcinoma were significantly associated with polymorphism in hsp70 genes.

KW - Cancer

KW - Heat shock proteins

KW - Polymorphism

KW - Tumor necrosis factor

UR - http://www.scopus.com/inward/record.url?scp=0030763626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030763626&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0142(19971015)80:8<1489::AID-CNCR17>3.0.CO;2-1

DO - 10.1002/(SICI)1097-0142(19971015)80:8<1489::AID-CNCR17>3.0.CO;2-1

M3 - Article

VL - 80

SP - 1489

EP - 1496

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 8

ER -